Treatment of Malignant Pleural Effusion: A Cost-Effectiveness Analysis

Slides:

Advertisements

Similar presentations

Metastasis of Pleural Mesothelioma Presenting as Bleeding Colonic Polyp Simone Sibio, MD, PhD, Paolo Sammartino, MD, PhD, Fabio Accarpio, MD, PhD, Daniele.

Advertisements

Changes in Risk Profile Over Time in the Population of a Pediatric Heart Transplant Program Olaf Reinhartz, MD, Katsuhide Maeda, MD, Bruce A. Reitz, MD,

Management of Malignant Pleural Effusions Using the Pleurx Catheter

Effusive Tuberculous Pericarditis

Melanie Subramanian, MD, Timothy McMurry, PhD, Bryan F

Evaluation of the Reliability of Clinical Staging of T2 N0 Esophageal Cancer: A Review of The Society of Thoracic Surgeons Database Traves D. Crabtree,

Endoscopic Ultrasound for Early Stage Esophageal Adenocarcinoma: Implications for Staging and Survival Traves D. Crabtree, MD, Wael N. Yacoub, MD, Varun.

A Propensity-Matched Comparison of Pleurodesis or Tunneled Pleural Catheter for Heart Failure Patients With Recurrent Pleural Effusion Richard K. Freeman,

Does the method of radiologic surveillance affect survival after resection of stage I non– small cell lung cancer? Traves D. Crabtree, MD, Varun Puri,

Paul J. Scheel, BS, Traves D. Crabtree, MD, Jennifer M

Diaphragmatic Defect Complicating Peritoneal Dialysis

Andranik Petrosyan, MD, Patrice Bergeron, MD

Clinical T2N0 Esophageal Cancer: Identifying Pretreatment Characteristics Associated With Pathologic Upstaging and the Potential Role for Induction Therapy

Teun J. Weijs, MD, PhD, Jelle P. Ruurda, MD, PhD, Maria E

Emanuela Taioli, MD, PhD, Andrea S

Michelle C. Ellis, MD, Brian S. Diggs, PhD, John T. Vetto, MD, Paul H

National Patterns of Care and Outcomes After Combined Modality Therapy for Stage IIIA Non–Small-Cell Lung Cancer Aalok P. Patel, BS, Traves D. Crabtree,

Varun Puri, MD, Andrew Tran, MS, Jennifer M. Bell, BS, Traves D

Eduardo Crema, PhD, MD, Lara B. P. Ribeiro, Juverson A. Terra, Alex A

Susanne Lison, MD, Michael Spannagl, MD, PhD, Wulf Dietrich, MD, PhD

Felix G. Fernandez, MD, Chadrick E. Denlinger, MD, G

Pleural Metastasis of Osteosarcoma

Adjuvant Chemotherapy Is Associated With Improved Survival in Locally Invasive Node Negative Non-Small Cell Lung Cancer Usman Ahmad, MD, Traves D. Crabtree,

Defining the Ideal Time Interval Between Planned Induction Therapy and Surgery for Stage IIIA Non-Small Cell Lung Cancer Pamela Samson, MD, MPHS, Traves.

Who Do You Say You Are? The Annals of Thoracic Surgery

The Role of Surgical Resection in Stage IIIA Non-Small Cell Lung Cancer: A Decision and Cost-Effectiveness Analysis Pamela Samson, MD, Aalok Patel, BS,

Tara R. Semenkovich, MD, MPHS, Christine Frederiksen, MS, Jessica L

Quality Measures in Clinical Stage I Non-Small Cell Lung Cancer: Improved Performance Is Associated With Improved Survival Pamela Samson, MD, MPHS, Traves.

Transthoracic Repair of Slipped Nissen Fundoplications: Technique and Results Ruchir Puri, MD, Adam M. Cline, MD, MS, Daniel T. DeArmond, MD, Scott B.

Use of Amiodarone After Major Lung Resection

Surgical Dilemmas: Diagnosis and Treatment of Atrial Plasmacytoma

Thomas Bruce Ferguson, MD, May 6, 1923–May 26, 2013

Use of a Pleural Implantable Access System for the Management of Malignant Pleural Effusion: The Institut Curie Experience Catherine Daniel, MD, Irène.

Treatment Outcomes in Stage I Lung Cancer

Mallory L. Irons, MD, MBE, J. William Gaynor, MD, Thomas L

Daniel C. Thomas, MD, MPH, Justin D. Blasberg, MD, Brian N

Dysphagia in the Young Male: The Ringed Esophagus

Yinin Hu, MD, Varun Puri, MD, Traves D

Extent of Lymphadenectomy Is Associated With Improved Overall Survival After Esophagectomy With or Without Induction Therapy Pamela Samson, MD, MPHS,

Embolized Methyl Methacrylate to the Right Atrium After Kyphoplasty

Mara B. Antonoff, MD, Varun Puri, MD, Bryan F

Daniel Kreisel, MD, PhD, Alexander S

Editorial Board, January 2010

Office-Based Spirometry: A New Model of Care in Preoperative Assessment for Low- Risk Lung Resections Jessica L. Hudson, MD, MPHS, Jennifer M. Bell, BSN,

Sarah C. Huen, MD, Chirag R. Parikh, MD, PhD

Ben M. Hunt, MD, Alexander S. Farivar, MD, Eric Vallières, MD, Brian E

Completely Thrombosed Tricuspid Pouch Mimicking a Cardiac Tumor

Rheumatoid Pleural Effusion in the Absence of Arthritic Disease

Postoperative Pleural Effusion in Bronchioloalveolar Cancer

Anirudh Vinnakota, MS, Robert Stewart, MD, Gosta Pettersson, MD, PhD

Adhering to Quality Measures in Esophagectomy Is Associated With Improved Survival in All Stages of Esophageal Cancer Pamela Samson, MD, MPHS, Varun.

Teruya Komatsu, MD, Harry Henteleff, MD The Annals of Thoracic Surgery

Stephen R. Broderick, MD, MPHS, Aalok P. Patel, BS, BA, Traves D

First Report on 30-day and Operative Mortality in Risk Model of Isolated Coronary Artery Bypass Grafting in Japan Noboru Motomura, MD, PhD, Hiroaki Miyata,

Shared Decision Making and Effective Risk Communication in the High-Risk Patient With Operable Stage I Non-Small Cell Lung Cancer Pamela Samson, MD,

Patterns of care in hilar node-positive (N1) non–small cell lung cancer: A missed treatment opportunity? Matthew J. Bott, MD, Aalok P. Patel, BS, Vivek.

Invited Commentary The Annals of Thoracic Surgery

Effects of Delayed Surgical Resection on Short-Term and Long-Term Outcomes in Clinical Stage I Non-Small Cell Lung Cancer Pamela Samson, MD, Aalok Patel,

Digital Drainage System Reduces Hospitalization After Video-Assisted Thoracoscopic Surgery Lung Resection Daniel L. Miller, MD, Gerald A. Helms, MD,

“Transitions” for Cardiothoracic Surgeons Now Listed on the Web:

A Propensity-Matched Comparison of Pleurodesis or Tunneled Pleural Catheter in Patients Undergoing Diagnostic Thoracoscopy for Malignancy Richard K.

Varun Puri, MD, Yinin Hu, MS, Tracey Guthrie, RN, Traves D

Late Consequences of a Much Earlier Decision

Lobectomy Versus Limited Resection in T1N0 Lung Cancer

Spencer J. Melby, MD, Shane J. Larue, MD, John M

The Impact of New Technology on Cardiothoracic Surgical Practice

Slide Tracheoplasty in Infants and Children: Risk Factors for Prolonged Postoperative Ventilatory Support Peter B. Manning, MD, Michael J. Rutter, MD,

John R. Handy, MD, HonD, Kelly Denniston, RHIT, Gary L

J. Alberto Lopez, MD The Annals of Thoracic Surgery

Lars Oddershede, MMS, Jan J. Andreasen, MD, PhD, Barbara C

Presentation transcript:

Treatment of Malignant Pleural Effusion: A Cost-Effectiveness Analysis Varun Puri, MD, Tanya L. Pyrdeck, RHIT, Traves D. Crabtree, MD, Daniel Kreisel, MD, PhD, Alexander S. Krupnick, MD, Graham A. Colditz, DrPH, G. Alexander Patterson, MD, Bryan F. Meyers, MD The Annals of Thoracic Surgery Volume 94, Issue 2, Pages 374-380 (August 2012) DOI: 10.1016/j.athoracsur.2012.02.100 Copyright © 2012 The Society of Thoracic Surgeons Terms and Conditions

Fig 1 Results of a 2-way sensitivity analysis varying the rate of complications with tunneled pleural catheter and risk of recurrence with bedside pleurodesis. It identifies which strategy is optimal in regions of values of the variables; thresholds are simply the border between two regions. As an example, if the rate of complications with TPC is 16%, BP would be the preferred option if rate of recurrence of effusion with BP is less than 33%. (TPC_compl = rate of complication with tunneled pleural catheter [expressed as a fraction]; BP_recurrent = rate of recurrence with bedside pleurodesis [expressed as a fraction]; wtp 50000 = willingness to pay set at $50,000/additional QALY gained.) The Annals of Thoracic Surgery 2012 94, 374-380DOI: (10.1016/j.athoracsur.2012.02.100) Copyright © 2012 The Society of Thoracic Surgeons Terms and Conditions